Oppenheimer Increases Sierra Oncology (NASDAQ:SRRA) Price Target to $45.00
Sierra Oncology (NASDAQ:SRRA – Get Rating) had its target price hoisted by analysts at Oppenheimer from $38.00 to $45.00 in a report released on Monday, The Fly reports. Oppenheimer’s price target points to a potential upside of 39.58% from the stock’s current price.